Search research articles
Contact Us
Filters
Showing results (41-50 of 98) with videos related to
Page
of 10
Sort By:
Therapeutic Drug Monitoring
|
February 1, 1994
Probable metabolic interaction between methadone and fluvoxamine in addict patients
G Bertschy, P Baumann, C B Eap, et al.
Revue Medicale Suisse
|
October 21, 2009
[Current topics in pharmacokinetics and pharmacogenetics of antidepressant drugs]
M Gex-Fabry, G Bertschy, M Kosel, et al.
Journal of Clinical Psychopharmacology
|
April 1, 1997
Fluvoxamine and fluoxetine do not interact in the same way with the metabolism of the enantiomers of methadone
C B Eap, G Bertschy, K Powell, et al.
Therapeutic Drug Monitoring
|
January 1, 1988
Valpromide increases the plasma concentrations of amitriptyline and its metabolite nortriptyline in depressive patients
S Vandel, G Bertschy, J M Jounet, et al.
Therapie
|
September 1, 1989
[Plasma desipramine levels and clinical response in patients with major depression. Results in agreement with a curvilinear relationship]
G Bertschy, S Vandel, B Vandel, et al.
L'Encephale
|
December 1, 1991
[Prediction of suicide risk]
D Sechter, B Bonin, G Bertschy, et al.
Therapie
|
March 1, 1994
Fluoxetine and norfluoxetine plasma levels after treatment discontinuation in man
S Vandel, G Bertschy, S Bouquet, et al.
European Journal of Clinical Pharmacology
|
January 1, 1991
Fluvoxamine-tricyclic antidepressant interaction. An accidental finding
G Bertschy, S Vandel, B Vandel, et al.
Psychopharmacology
|
December 1, 1996
Non-response to citalopram in depressive patients: pharmacokinetic and clinical consequences of a fluvoxamine augmentation
G Bondolfi, C Chautems, B Rochat, et al.
European Journal of Clinical Pharmacology
|
January 1, 1990
Tricyclic antidepressant plasma level monitoring: intraindividual variability in everyday practice
S Vandel, G Bertschy, S Nezeloff, et al.
Page
of 10
Search research articles
Search
Showing results (41-50 of 98) with videos related to
Sort By:
Page
of 10
Therapeutic Drug Monitoring
|
February 1, 1994
Probable metabolic interaction between methadone and fluvoxamine in addict patients
G Bertschy, P Baumann, C B Eap, et al.
Revue Medicale Suisse
|
October 21, 2009
[Current topics in pharmacokinetics and pharmacogenetics of antidepressant drugs]
M Gex-Fabry, G Bertschy, M Kosel, et al.
Journal of Clinical Psychopharmacology
|
April 1, 1997
Fluvoxamine and fluoxetine do not interact in the same way with the metabolism of the enantiomers of methadone
C B Eap, G Bertschy, K Powell, et al.
Therapeutic Drug Monitoring
|
January 1, 1988
Valpromide increases the plasma concentrations of amitriptyline and its metabolite nortriptyline in depressive patients
S Vandel, G Bertschy, J M Jounet, et al.
Therapie
|
September 1, 1989
[Plasma desipramine levels and clinical response in patients with major depression. Results in agreement with a curvilinear relationship]
G Bertschy, S Vandel, B Vandel, et al.
L'Encephale
|
December 1, 1991
[Prediction of suicide risk]
D Sechter, B Bonin, G Bertschy, et al.
Therapie
|
March 1, 1994
Fluoxetine and norfluoxetine plasma levels after treatment discontinuation in man
S Vandel, G Bertschy, S Bouquet, et al.
European Journal of Clinical Pharmacology
|
January 1, 1991
Fluvoxamine-tricyclic antidepressant interaction. An accidental finding
G Bertschy, S Vandel, B Vandel, et al.
Psychopharmacology
|
December 1, 1996
Non-response to citalopram in depressive patients: pharmacokinetic and clinical consequences of a fluvoxamine augmentation
G Bondolfi, C Chautems, B Rochat, et al.
European Journal of Clinical Pharmacology
|
January 1, 1990
Tricyclic antidepressant plasma level monitoring: intraindividual variability in everyday practice
S Vandel, G Bertschy, S Nezeloff, et al.
Page
of 10